logo

Latest Financial Updates

Read latest financial news update from our blog

‘MindsEye’ Promises Huge Fixes As Its Playercount Flatlines
‘MindsEye’ Promises Huge Fixes As Its Playercount Flatlines

MindsEye Rocketboy MindsEye is quickly becoming a cautionary tale including lessons like...

Admin | Finance | 3 days ago

FERMAT Raises $45M Series B
FERMAT Raises $45M Series B

FERMAT Raises $45M Series B Back to Home SAN FRANCISCO, CA, FERMAT, the AI-native commerc...

Admin | Finance | 3 days ago

Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test
Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test

Winner Chao Wang of Arizona State University will receive $150,000 to evaluate a unique di...

Admin | Finance | 3 days ago

Difficult day for us at Air India, team working to support the needy: CEO Wilson
Difficult day for us at Air India, team working to support the needy: CEO Wilson

Air India CEO and Managing Director Campbell Wilson on Thursday expressed "deep sorrow" at...

Admin | Finance | 3 days ago

Voith to modernisation three hydropower stations in Malaysia
Voith to modernisation three hydropower stations in Malaysia

The consortium comprising Voith and HeiTech Padu Berhad (HeiTech), a technology company lo...

Admin | Finance | 3 days ago

MLC 2025: Major League Cricket Schedule, Match Timings, Live Streaming, Squads And More
MLC 2025: Major League Cricket Schedule, Match Timings, Live Streaming, Squads And More

MLC 2025: Major League Cricket (MLC) is a professional T20 cricket league conducted in the...

Admin | Finance | 3 days ago

Fashion Company Bonprix to Implement Trustly A2A Payments
Fashion Company Bonprix to Implement Trustly A2A Payments

Fashion company Bonprix will implement Trustly’s account-to-account (A2A) payment solution...

Admin | Finance | 3 days ago

COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments

Key Takeaways BioNTech is buying fellow German firm CureVac for approximately $1.25 billio...

Admin | Finance | 3 days ago

Join Our Newsletter

join our newsletter to receive update from us